I. Yildiz Et Al. , "Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma," CLINICAL GENITOURINARY CANCER , vol.11, no.3, pp.290-296, 2013
Yildiz, I. Et Al. 2013. Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma. CLINICAL GENITOURINARY CANCER , vol.11, no.3 , 290-296.
Yildiz, I., Sen, F., Kilic, L., Keskin, S., Duranyildiz, D., Bilgin, E., ... Disci, R.(2013). Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma. CLINICAL GENITOURINARY CANCER , vol.11, no.3, 290-296.
Yildiz, Ibrahim Et Al. "Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma," CLINICAL GENITOURINARY CANCER , vol.11, no.3, 290-296, 2013
Yildiz, Ibrahim Et Al. "Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma." CLINICAL GENITOURINARY CANCER , vol.11, no.3, pp.290-296, 2013
Yildiz, I. Et Al. (2013) . "Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma." CLINICAL GENITOURINARY CANCER , vol.11, no.3, pp.290-296.
@article{article, author={Ibrahim Yildiz Et Al. }, title={Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma}, journal={CLINICAL GENITOURINARY CANCER}, year=2013, pages={290-296} }